Article
Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach.
Biochemical and biophysical research communications - 9 Sept 2011
Amniai Laziza, Lippens Guy, Landrieu Isabelle
Abstract excerpt
We present here the characterization of the epitope recognized by the AT180 monoclonal antibody currently used to define an Alzheimer's disease (AD)-related pathological form of the phosphorylated Tau protein. Some ambiguity remains as to the exact phospho-residue(s) recognized by this monoclonal: pThr231 or both pThr231 and pSer235. To answer this question, we have used a combination of nuclear magnetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
